Previous 10 | Next 10 |
DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on November 21, 2023 the Company received n...
DUBLIN, Ireland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, welcomes the recent decision by the High Court of Kenya. The cour...
2023-10-03 14:41:05 ET Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript October 3, 2023 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, Investor Relations Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer ...
2023-10-03 10:46:09 ET Trinity Biotech press release ( NASDAQ: TRIB ): Q2 Total revenue for fiscal Q2, 2023 was $13.9m. Loss per ADS of 15.6 cents. Revenue outlook for Q3 is expected to be approximately $14m to $15m. In addition, order backlogs have increased sub...
DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2023. Summa...
Trinity Biotech plc (TRIB) is expected to report $-0.07 for Q3 2023 Vicapsys Life Sciences Inc (VICP) is expected to report for quarter end 2023-06-30 Innotech Corp (INTH) is expected to report for quarter end 2023-06-30 Village Super Market Inc. Class A Common Stock (VLGEA) is expect...
Trinity Biotech plc (TRIB) is expected to report $-0.07 for Q3 2023
2023-10-02 12:28:44 ET Major earnings expected before the bell on Tuesday include: McCormick & Company ( MKC ) Trinity Biotech ( TRIB ) For Seeking Alpha's full earnings season calendar, click here . For further details see: Notable earnings before Tu...
2023-10-02 11:21:01 ET More on Trinity Biotech Seeking Alpha’s Quant Rating on Trinity Biotech Historical earnings data for Trinity Biotech Financial information for Trinity Biotech For further details see: Trinity Biotech Q2 2023 Earnings Preview
DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2023 on Tuesday, October 3, 2023. The ...
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...